| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |